---
schema_version: "secwatch.filing_event.v1"
accession: "0001837607-26-000052"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2026-07-15T20:01:21+00:00"
generated_at: "2026-07-15T20:02:04.169580+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AEON Biopharma prices upsized $13.75M public offering with milestone warrants for potential $29.6M additional proceeds

## Summary
- Offering of 42,688,606 shares (or pre-funded warrants) plus two-year and five-year milestone warrants at combined price of $0.3221 per share.
- Gross proceeds of ~$13.75M; up to $29.6M more if all milestone warrants exercised for cash.
- Net proceeds of ~$12.2M to be used for working capital and ABP-450 biosimilar testing.
- Underwriters granted 30-day over-allotment option for up to 6,403,290 additional shares/warrants.
- Offering closed July 15, 2026; lock-up agreements for 90 days from closing.

## SEC filing metadata
- accession: 0001837607-26-000052
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2026-07-15T20:01:21+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000183760726000052/0001837607-26-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000183760726000052/aeon-20260713x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001837607-26-000052
- JSON: https://secwatch.observer/filing/0001837607-26-000052.json
- Plain text: https://secwatch.observer/filing/0001837607-26-000052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.